Sultan_2025_BMJ.Case.Rep_18_

Reference

Title : Successful resolution of Capgras syndrome with rivastigmine treatment in Lewy body dementia - Sultan_2025_BMJ.Case.Rep_18_
Author(s) : Sultan R , Bouhenni R , Sasse J , Balachandran S
Ref : BMJ Case Rep , 18 : , 2025
Abstract :

Capgras syndrome, a delusional misidentification syndrome characterized by the belief that a close relative or friend has been replaced by an identical imposter, is a rare phenomenon often associated with psychotic disorders. Here, we present a case of a male in his early 80s with Lewy body dementia (LBD) who developed Capgras syndrome. Despite initial challenges in management, including thought blocking and word-finding difficulty, the patient experienced complete resolution of symptoms following treatment with rivastigmine, a cholinesterase inhibitor, commonly used in major neurocognitive disorders. This case highlights the potential efficacy of cholinesterase inhibitors in alleviating psychotic symptoms associated with Capgras syndrome, particularly in individuals with LBD.

PubMedSearch : Sultan_2025_BMJ.Case.Rep_18_
PubMedID: 41224365

Related information

Inhibitor Rivastigmine

Citations formats

Sultan R, Bouhenni R, Sasse J, Balachandran S (2025)
Successful resolution of Capgras syndrome with rivastigmine treatment in Lewy body dementia
BMJ Case Rep 18 :

Sultan R, Bouhenni R, Sasse J, Balachandran S (2025)
BMJ Case Rep 18 :